The know-how and expertise of the IPMB team allows you to benefit from

Global regulatory approvals

• Excellent relationships to key Regulatory Agencies, e.g. national European Agencies, EMEA, CHMP, FDA, TPD, TGA 
• Extensive experience in Global Regulatory Affairs, Drug Development, Clinical Development and Project Management  
• Specific regulatory know-how in therapeutic areas, e.g: Respiratory, Gastroenterology, Cardiovascular, CNS, Imaging  
• Hands-on experience with NCEs, biologicals, line extensions, generics, orphan drugs, OTC, medical devices  
• A proven track record of numerous approvals, including Pantoprazole, in the EU, the US, Japan, Canada, Australia, Latin America, Asia, the Middle East and Africa.